首页> 外文OA文献 >The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory hodgkin disease: A southwest oncology group phase II trial

【2h】

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory hodgkin disease: A southwest oncology group phase II trial

机译：西南肿瘤小组II期试验：增强的制备疗法与自体骨髓移植联合治疗复发性或难治性霍奇金病的价值

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Stiff Patrick J; Unger Joseph M; Forman Stephen J; McCall Anne R; LeBlanc Michael; Nademanee Auayporn P; Bolwell Brian J; Fisher Richard I;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 大剂量化疗联合外周血干细胞移植治疗复发性或难治性霍奇金病:远期疗效及预后因子 [J] . 孙岚, 孙汉英中德临床肿瘤学杂志（英文版） . 2001,第004期
2. The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory hodgkin disease: A southwest oncology group phase II trial. [J] . Stiff PJ, Unger JM, Forman SJ, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2003,第8期

机译：西南肿瘤小组II期试验：增强的制备疗法与自体骨髓移植联合治疗复发性或难治性霍奇金病的价值。
3. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial. [J] . Stiff PJ, Dahlberg S, Forman SJ, Journal of Clinical Oncology . 1998,第1期

机译：自体骨髓移植治疗复发性或难治性弥漫性侵袭性非霍奇金淋巴瘤的患者：增强的治疗方案的价值－一项西南肿瘤小组的试验。
4. Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO) [J] . Garcia-Sanz Ramon, Sureda Anna, Gonzalez Ana Pilar, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：Brentuximab Vedotin加ESHAP（BRESHAP）是一种有效的组合，可在自体干细胞移植之前诱导难治性和复发性霍奇金淋巴瘤患者的缓解：西班牙淋巴瘤和骨髓移植（GELTAMO）试验
5. Vasoactive Intestinal Polypeptide Induces Regulatory Dendritic Cells Thai Prevent Acute Graft Versus Host Disease and Leukemia Relapse after Bone Marrow Transplantation [C] . MARIO DELGADO, ALEJO CHORNY, DOINA GANEA, International Symposium on VIP, PACAP, and Related Peptides . 2006

机译：血管活性肠道多肽诱导调节性树突细胞泰国预防急性移植物与骨髓移植后宿主病和白血病复发
6. Phase I/II Trial of GN-BVC a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma [O] . Sally Arai, Renee Letsinger, Ruby M. Wong, -1

机译：相I / GN-BVC吉西他滨和长春瑞滨含养生调理II试验进行自体造血干细胞移植治疗复发难治霍奇金淋巴瘤
7. ABCL-014: Gemcitabine and Docetaxel Protocol as Intent to Autologous Bone Marrow Transplantation in Patients with Refractory and Relapsed Non-Hodgkin Lymphoma: Single Institutional Prospective Phase II Study [O] . Doaa H. Sakr, Maryan Waheeb Fahmi, Mohamed A. Ebrahim, 2020

机译：ABCL-014：Gemcitabine和Docetaxel议定书目的是难治性和复发的非霍奇金淋巴瘤患者的自体骨髓移植：单一制度前瞻性研究

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory hodgkin disease: A southwest oncology group phase II trial

著录项

相似文献

相关主题

期刊订阅